Blau Farmacêutica S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was BRL 1,040.21 million compared to BRL 1,016.51 million a year ago. Net income was BRL 268.39 million compared to BRL 280.05 million a year ago. Basic earnings per share from continuing operations was BRL 1.5092 compared to BRL 1.6623 a year ago. Diluted earnings per share from continuing operations was BRL 1.5092 compared to BRL 1.6623 a year ago.